Humedix Co., Ltd. Logo

Humedix Co., Ltd.

Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.

200670 | KO

Overview

Corporate Details

ISIN(s):
KR7200670008
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 6층 603호, 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Humedix Co., Ltd. is a global healthcare company dedicated to developing technologies that enhance human health and beauty. The company's operations encompass pharmaceuticals, medical devices, and functional cosmetics. Its core product lines include arthritis treatments, aesthetic solutions such as dermal fillers and botulinum toxin, and various cosmeceuticals, with a particular specialization in hyaluronic acid-based raw materials and finished goods. In addition to its proprietary products, Humedix provides Contract Manufacturing Organization (CMO) services, leveraging its significant production capacity. As an affiliate of the Huons Group, the company is focused on expanding its presence in international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.3 KB
2025-08-29 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정 (중간배당)
Korean 12.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-08-08 00:00
Major Shareholding Notification
신탁계약에의한취득상황보고서
Korean 23.8 KB
2025-08-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 115.3 KB
2025-08-06 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.4 KB
2025-08-06 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (중간배당)
Korean 8.6 KB
2025-07-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.4 KB
2025-07-25 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-07-09 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-24 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 5.1 KB
2025-06-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 70.7 KB
2025-06-09 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 51.4 KB

Automate Your Workflow. Get a real-time feed of all Humedix Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Humedix Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Humedix Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.